| Lindsey Nelson, OD | |
|
116 N Tuscola Rd, Bay City, MI 48708-6961 | |
| (989) 892-9595 | |
| Not Available |
| Full Name | Lindsey Nelson |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 4 Years |
| Location | 116 N Tuscola Rd, Bay City, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063034924 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901005445 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Great Lakes Bay Health Centers | 2466369046 | 65 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.
Traditional decision aids to help patient-doctor discussions have drawbacks, but a new electronic model developed by McMaster University researchers holds promise of revolutionizing shared decision-making in the doctor's office with the touch of an electronic tablet.
Conventional methods of assessing cardiorespiratory fitness and muscular strength among people with multiple sclerosis may underestimate participants' capabilities, prompting clinicians to prescribe exercise therapies that are less effective than they could be, according to new research by scientists at the University of Illinois.
Magellan Health Services, Inc. today reported financial results for the second quarter of 2010 and increased guidance for the full year. The Company also said that its Board of Directors approved a share repurchase program under which the Company is authorized to purchase up to $350 million of its outstanding common stock.
Composite Software, the leading provider of data virtualization software, today announced that a senior executive from Pfizer (a Composite customer) and a senior Composite executive will present at the Butler Group's Business Intelligence (BI) Symposium. "BI Foundations for Decision-Making Excellence and Risk Management" is scheduled for October 7-8, 2009, at the America Square Conference Centre in London.
› Verified 5 days ago
| Provider Name | Great Lakes Bay Health Centers |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1871684761 PECOS PAC ID: 2466369046 Enrollment ID: O20040126000171 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.
Traditional decision aids to help patient-doctor discussions have drawbacks, but a new electronic model developed by McMaster University researchers holds promise of revolutionizing shared decision-making in the doctor's office with the touch of an electronic tablet.
Conventional methods of assessing cardiorespiratory fitness and muscular strength among people with multiple sclerosis may underestimate participants' capabilities, prompting clinicians to prescribe exercise therapies that are less effective than they could be, according to new research by scientists at the University of Illinois.
Magellan Health Services, Inc. today reported financial results for the second quarter of 2010 and increased guidance for the full year. The Company also said that its Board of Directors approved a share repurchase program under which the Company is authorized to purchase up to $350 million of its outstanding common stock.
Composite Software, the leading provider of data virtualization software, today announced that a senior executive from Pfizer (a Composite customer) and a senior Composite executive will present at the Butler Group's Business Intelligence (BI) Symposium. "BI Foundations for Decision-Making Excellence and Risk Management" is scheduled for October 7-8, 2009, at the America Square Conference Centre in London.
› Verified 5 days ago
| Provider Name | Bay Eye Care Center, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235168915 PECOS PAC ID: 7012900319 Enrollment ID: O20040405000270 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.
Traditional decision aids to help patient-doctor discussions have drawbacks, but a new electronic model developed by McMaster University researchers holds promise of revolutionizing shared decision-making in the doctor's office with the touch of an electronic tablet.
Conventional methods of assessing cardiorespiratory fitness and muscular strength among people with multiple sclerosis may underestimate participants' capabilities, prompting clinicians to prescribe exercise therapies that are less effective than they could be, according to new research by scientists at the University of Illinois.
Magellan Health Services, Inc. today reported financial results for the second quarter of 2010 and increased guidance for the full year. The Company also said that its Board of Directors approved a share repurchase program under which the Company is authorized to purchase up to $350 million of its outstanding common stock.
Composite Software, the leading provider of data virtualization software, today announced that a senior executive from Pfizer (a Composite customer) and a senior Composite executive will present at the Butler Group's Business Intelligence (BI) Symposium. "BI Foundations for Decision-Making Excellence and Risk Management" is scheduled for October 7-8, 2009, at the America Square Conference Centre in London.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Nelson, OD 580 Lakes Edge Dr, Oxford, MI 48371-5227 Ph: (248) 891-1349 | Lindsey Nelson, OD 116 N Tuscola Rd, Bay City, MI 48708-6961 Ph: (989) 892-9595 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.
Traditional decision aids to help patient-doctor discussions have drawbacks, but a new electronic model developed by McMaster University researchers holds promise of revolutionizing shared decision-making in the doctor's office with the touch of an electronic tablet.
Conventional methods of assessing cardiorespiratory fitness and muscular strength among people with multiple sclerosis may underestimate participants' capabilities, prompting clinicians to prescribe exercise therapies that are less effective than they could be, according to new research by scientists at the University of Illinois.
Magellan Health Services, Inc. today reported financial results for the second quarter of 2010 and increased guidance for the full year. The Company also said that its Board of Directors approved a share repurchase program under which the Company is authorized to purchase up to $350 million of its outstanding common stock.
Composite Software, the leading provider of data virtualization software, today announced that a senior executive from Pfizer (a Composite customer) and a senior Composite executive will present at the Butler Group's Business Intelligence (BI) Symposium. "BI Foundations for Decision-Making Excellence and Risk Management" is scheduled for October 7-8, 2009, at the America Square Conference Centre in London.
› Verified 5 days ago
Kristin M Sansburn, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 116 N Tuscola Rd, Bay City, MI 48708 Phone: 989-892-9595 Fax: 989-892-3080 | |
Ms. Leslie K Delemeester, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4100 East Wilder Rd, Bay City, MI 48706 Phone: 269-349-7627 Fax: 269-342-4284 | |
Richard Eric Strain, O.d., P.l.c. Optometrist Medicare: Medicare Enrolled Practice Location: 600 S Euclid Ave, Bay City, MI 48706 Phone: 989-684-8840 | |
Dr. Patrick Paul Ruggles, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3801 Wilder Rd, Ste 4, Bay City, MI 48706 Phone: 989-778-1414 Fax: 989-402-1467 | |
Roy A Golsch, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4101 Wilder Rd, Ste B 211 Bay City Mall, Bay City, MI 48706 Phone: 989-684-9233 Fax: 989-684-6597 | |
Matthew S. Pestrue Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3921 Wilder Rd, Bay City, MI 48706 Phone: 989-684-5526 Fax: 989-684-7513 |